118 related articles for article (PubMed ID: 37027950)
21. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).
Li Y; Wang W; Xu X; Sun S; Qu XJ
Biomed Pharmacother; 2015 Feb; 69():125-32. PubMed ID: 25661348
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
24. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.
Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513
[TBL] [Abstract][Full Text] [Related]
25. 6-Shogaol induces cell cycle arrest and apoptosis in human hepatoma cells through pleiotropic mechanisms.
Wu JJ; Omar HA; Lee YR; Teng YN; Chen PS; Chen YC; Huang HS; Lee KH; Hung JH
Eur J Pharmacol; 2015 Sep; 762():449-58. PubMed ID: 26101062
[TBL] [Abstract][Full Text] [Related]
26. Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer.
Bai Y; Liang C; Zhou J; Liu Y; Wang F; Gao J; Wu J; Hu D
Eur J Med Chem; 2023 Nov; 259():115656. PubMed ID: 37499289
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis oxidative damage-mediated and antiproliferative effect of selenylated imidazo[1,2-a]pyridines on hepatocellular carcinoma HepG2 cells and in vivo.
Dos Santos DC; Rafique J; Saba S; Almeida GM; Siminski T; Pádua C; Filho DW; Zamoner A; Braga AL; Pedrosa RC; Ourique F
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22663. PubMed ID: 33125183
[TBL] [Abstract][Full Text] [Related]
28. Vibsane-type diterpenoids from Viburnum odoratissimum inhibit hepatocellular carcinoma cells via the PI3K/AKT pathway.
Xue XB; Lv TM; Hou JY; Li DQ; Huang XX; Song SJ; Yao GD
Phytomedicine; 2023 Jan; 108():154499. PubMed ID: 36270223
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
[TBL] [Abstract][Full Text] [Related]
30. HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro.
Zhou Y; Lu N; Zhang H; Wei L; Tao L; Dai Q; Zhao L; Lin B; Ding Q; Guo Q
Eur J Pharm Sci; 2013 Jul; 49(4):649-58. PubMed ID: 23619285
[TBL] [Abstract][Full Text] [Related]
31. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells.
Chen X; Zhao Y; Luo W; Chen S; Lin F; Zhang X; Fan S; Shen X; Wang Y; Liang G
Theranostics; 2020; 10(22):10290-10308. PubMed ID: 32929349
[No Abstract] [Full Text] [Related]
32. meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
Limpachayaporn P; Nuchpun S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Tangkijvanich P; Suksamrarn A
Bioorg Med Chem; 2022 Nov; 74():117048. PubMed ID: 36270111
[TBL] [Abstract][Full Text] [Related]
33. W436, a novel SMART derivative, exhibits anti-hepatocarcinoma activity by inducing apoptosis and G2/M cell cycle arrest in vitro and in vivo and induces protective autophagy.
Man S; Wu Z; Sun R; Guan Q; Li Z; Zuo D; Zhang W; Wu Y
J Biochem Mol Toxicol; 2021 Aug; 35(8):e22831. PubMed ID: 34155709
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Harras MF; Sabour R
Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity.
Bian M; Wang X; Sun Y; Liu W
Eur J Med Chem; 2020 May; 193():112234. PubMed ID: 32213395
[TBL] [Abstract][Full Text] [Related]
36. Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosis.
Guo L; Tan K; Wang H; Zhang X
Oncol Rep; 2016 Dec; 36(6):3233-3240. PubMed ID: 27748853
[TBL] [Abstract][Full Text] [Related]
37. Calycosin induces mitochondrial-dependent apoptosis and cell cycle arrest, and inhibits cell migration through a ROS-mediated signaling pathway in HepG2 hepatocellular carcinoma cells.
Liu Y; Piao XJ; Xu WT; Zhang Y; Zhang T; Xue H; Li YN; Zuo WB; Sun G; Fu ZR; Luo YH; Jin CH
Toxicol In Vitro; 2021 Feb; 70():105052. PubMed ID: 33188878
[TBL] [Abstract][Full Text] [Related]
38. 3,3'-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis.
Munakarmi S; Shrestha J; Shin HB; Lee GH; Jeong YJ
Cells; 2021 May; 10(5):. PubMed ID: 34066056
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting.
Xu ZW; Wang FM; Gao MJ; Chen XY; Hu WL; Xu RC
Biol Pharm Bull; 2010; 33(5):743-51. PubMed ID: 20460749
[TBL] [Abstract][Full Text] [Related]
40. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
